Health
COVID-19 drug remdesivir has been a big win for Gilead — and it got a boost from taxpayers – San Francisco Chronicle
With U.S. cases skyrocketing, demand for the Foster City company’s antiviral drug is only growing. Biden appointees have proposed potential legal tactics to tamp…
It was the end of April — just as the U.S. confirmed its millionth COVID-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir.
That was surprising because the antiviral drug, owned by Gilead Sciences and developed with investment from the federal government, had languished for years with no apparent commercial use. It had struck out as a treatment for hepatitis C and Ebola.
But early in 2020, when the first global…
-
Noosa News23 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News24 hours agoE-biker charged with riding dangerously, assaulting cop
-
Business17 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General22 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands